EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Accelerated drug-resistant variant discovery with an enhanced, scalable mutagenic base editor platform

Kristel M Dorighi, Anqi Zhu, Jean-Philippe Fortin, Jerry Hung-Hao Lo, Jawahar Sudhamsu, Timothy J Wendorff, Steffen Durinck, Marinella Callow, Scott A Foster, Benjamin Haley

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Kristel M Dorighi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: dorighik@gene.com. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, ErbB Receptors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Genentech Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmErbB ReceptorsHumansCell Line, TumorGene EditingProto-Oncogene Proteins B-rafCRISPR-Cas SystemsMutationMutagenesis

Stichwörter der Autor:innen

AIDBRAFCP: CancerCRISPR-Cas9EGFRbase editingdrug resistancefunctional genomicsmutagenesis

Substanzen

ErbB ReceptorsProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Department of Molecular Biology, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: dorighik@gene.com.
  • Department of OMNI Bioinformatics, Genentech, Inc., South San Francisco, CA 94080, USA.
  • Department of Data Science and Statistical Computing, Genentech, Inc., South San Francisco, CA 94080, USA.
  • Department of Oncology Bioinformatics, Genentech, Inc., South San Francisco, CA 94080, USA.
  • Department of Structural Biology, Genentech, Inc., South San Francisco, CA 94080, USA.
  • Department of Discovery Oncology, Genentech, Inc., South San Francisco, CA 94080, USA.

Förderung

  • Genentech Inc

Zitieren

APA

Dorighi, K. M., Zhu, A., Fortin, J. P., Hung-Hao Lo, J., Sudhamsu, J., Wendorff, T. J., Durinck, S., Callow, M., Foster, S. A., & Haley, B. (2024). Accelerated drug-resistant variant discovery with an enhanced, scalable mutagenic base editor platform. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114313

Vancouver

Dorighi KM, Zhu A, Fortin JP, Hung-Hao Lo J, Sudhamsu J, Wendorff TJ, et al. Accelerated drug-resistant variant discovery with an enhanced, scalable mutagenic base editor platform. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114313

BibTeX
@article{Dorighi2024,
  author = {Dorighi, Kristel M and Zhu, Anqi and Fortin, Jean-Philippe and Hung-Hao Lo, Jerry and Sudhamsu, Jawahar and Wendorff, Timothy J and Durinck, Steffen and Callow, Marinella and Foster, Scott A and Haley, Benjamin},
  title = {Accelerated drug-resistant variant discovery with an enhanced, scalable mutagenic base editor platform},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114313}
}
Kostenlos starten →